Christopher Scott Selected Research

cenderitide

1/2018

A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher Scott Research Topics

Disease

15	Breast Neoplasms (Breast Cancer) 02/2023 - 08/2015
10	Neoplasms (Cancer) 01/2021 - 05/2005
4	Heart Failure 01/2022 - 08/2004
3	Atrophy 04/2024 - 01/2020
3	Hypertension (High Blood Pressure) 01/2024 - 03/2007
3	Pain (Aches) 01/2022 - 06/2012
2	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 10/2019
2	Dementia (Dementias) 01/2023 - 01/2020
2	Cognitive Dysfunction 01/2023 - 10/2019
2	Triple Negative Breast Neoplasms 01/2021 - 01/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015 - 04/2013
2	Inflammation (Inflammations) 01/2015 - 03/2006
2	Hypoxia (Hypoxemia) 08/2014 - 06/2010
2	Mitral Valve Insufficiency (Mitral Regurgitation) 04/2006 - 05/2005
1	Cerebral Small Vessel Diseases 04/2024
1	Mixed Dementias 04/2024
1	Insulin Resistance 01/2024
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024
1	Stroke (Strokes) 07/2023
1	Cellulitis 01/2022
1	Osteonecrosis (Kienbock's Disease) 05/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	COVID-19 01/2020
1	Disease Progression 01/2020
1	Transient Ischemic Attack 10/2019
1	Leukoencephalopathies 10/2019
1	Lacunar Stroke 10/2019
1	Alcoholic Fatty Liver 01/2019
1	Chromosome Fragility 01/2019
1	Metabolic Diseases (Metabolic Disease) 01/2018
1	Wounds and Injuries (Trauma) 05/2017
1	Chronic Renal Insufficiency 01/2017
1	Acute Kidney Injury (Acute Renal Failure) 01/2017
1	Body Weight (Weight, Body) 01/2015
1	Ventricular Dysfunction 01/2014
1	Fibrosis (Cirrhosis) 04/2013

Drug/Important Bio-Agent (IBA)

7	Hormones (Hormone)IBA 01/2022 - 08/2015
5	Estrogen ReceptorsIBA 01/2021 - 04/2016
4	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2006
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 06/2010
3	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2019 - 05/2005
2	Amyloid beta-PeptidesIBA 04/2024 - 01/2023
2	Amyloid (Amyloid Fibrils)IBA 04/2024 - 01/2023
2	Natriuretic PeptidesIBA 01/2024 - 01/2014
2	Atrial Natriuretic Factor (ANF)IBA 01/2024 - 10/2019
2	mahuang-tangIBA 01/2022 - 08/2015
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2011
1	atrial natriuretic factor receptor AIBA 01/2024
1	Apolipoprotein E4IBA 07/2023
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2022
1	Tadalafil (Cialis)FDA Link 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Diphosphonates (Bisphosphonates)IBA 05/2021
1	Denosumab FDA Link 05/2021
1	Progesterone FDA LinkGeneric 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	EpitopesIBA 01/2020
1	Tamoxifen FDA LinkGeneric 01/2020
1	Homeodomain Proteins (Proteins, Homeobox)IBA 01/2020
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2020
1	florbetapirIBA 10/2019
1	Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA 01/2019
1	olaparibIBA 01/2019
1	antineoplaston A10 (A 10)IBA 01/2019
1	A-Form DNA (A-DNA)IBA 01/2019
1	diepoxybutaneIBA 01/2019
1	cenderitideIBA 01/2018
1	Cyclic GMPIBA 01/2018
1	AldosteroneIBA 01/2018
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2018
1	Antihypertensive Agents (Antihypertensives)IBA 01/2018
1	insulin-like growth factor binding protein-related protein 1IBA 01/2017
1	Insulin-Like Growth Factor Binding ProteinsIBA 01/2017
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 08/2015
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 08/2015
1	Thioacetamide (Thioacetamid)IBA 01/2015
1	endothelial PAS domain-containing protein 1IBA 01/2015
1	CollagenIBA 01/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	Deferoxamine (Desferal)FDA LinkGeneric 08/2014
1	LigandsIBA 04/2013
1	Calcitriol Receptors (Calcitriol Receptor)IBA 04/2013
1	Anti-Anxiety Agents (Anxiolytics)IBA 06/2012
1	SuspensionsIBA 10/2011

Therapy/Procedure

9	Therapeutics 01/2022 - 07/2008
2	Radiotherapy 02/2023 - 01/2023
1	Subcutaneous Injections 01/2024
1	Analgesia 01/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Neoadjuvant Therapy 01/2021
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2017
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2017
1	Intraperitoneal Injections 01/2015
1	Surgical Amputation (Amputations) 06/2012
1	Quantum Dots (Quantum Dot) 10/2011